Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology | Nephrology | Family Medicine
Renal Cell Carcinoma Clinical Trials
A listing of Renal Cell Carcinoma medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.
Alabama
Muscle Shoals : Northwest Alabama Cancer Center
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Arizona
Scottsdale :
AMG 172 First in Human Study in Patients With Kidney Cancer
Scottsdale : Research Site
AMG 172 First in Human Study in Patients With Kidney Cancer
Arkansas
Hot Springs : Genesis Cancer Center
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
California
Burbank : Providence Health System: Roy and Patricia Disney Family Cancer Center
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Corona : Compassionate Cancer Care Medical Group
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Corona : Compassionate Cancer Care Medical Group, Inc.
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Duarte : City of Hope
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Fountain Valley : Robert A. Moss, M.D., FACP, Inc.
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
View More »
Fresno : California Cancer Associates for Research and Excellence
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Greenbrae : Marin Specialty Care
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Los Angeles : Good Samaritan Hospital
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Los Angeles : UCLA Med - Hematology & Oncology
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Los Angeles : Samuel Oschin Cancer Center at Cedars-Sinai Medical Center Updated
Phase 3 Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (RCC)
Riverside : Compassionate Cancer Care Medical Group
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
San Francisco : Ucsf Helen Diller Family Comprehensive Cancer Center
Phase I Biomarker Study (BMS-936558)
Stanford : Stanford Cancer Center
A Phase 1b Study of SGN-75 in Combination With Everolimus in Patients With Renal Cell Carcinoma
Whittier : American Institute of Research
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Colorado
Denver : The Urology Center of Colorado
An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)
View More »
Denver : Centura Health Research Center
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Denver : The Urology Center of Colorado Updated
Phase 3 Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (RCC)
Golden : Western Oncology & Hematology
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Parker : Advanced Urology, P.C. Updated
Phase 3 Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (RCC)
Connecticut
Florida
Brooksville : Cancer Care Centers of Florida: Brooksville
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Ft Lauderdale : Broward Oncology Associates
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Gainesville : University of Florida, Shands Cancer Center
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Jacksonville : Cancer Specialists of North Florida
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Miami : Advanced Pharma CR, LLC
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
View More »
Miami Beach : Research Site
A Phase 1 Study to Evaluate MEDI4736
New Port Richey : Cancer Care Centers of Florida
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Ocala : Ocala Cancer Institute
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Rockledge : Cancer Care Centers of Brevard
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Tampa : Research Site
A Phase 1 Study to Evaluate MEDI4736
Tampa : H Lee Moffitt Cancer Center
Phase I Biomarker Study (BMS-936558)
Georgia
Savannah : Memorial University Medical Center
CALBG 90802: Randomized Phase III Trial Comparing Everolimus Plus Placebo Versus Everolimus Plus Bevacizumab for Advanced Renal Cell Carcinoma Progressing After Treatment With Tyrosine Kinase Inhibitors
View More »
Athens : Northeast Georgia Cancer Care, LLC
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Atlanta : Emory Univeristy Hospital Updated
Phase 3 Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (RCC)
Augusta : Research Site
A Phase 1 Study to Evaluate MEDI4736
Dublin : Dublin Hematology & Oncology Care
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Idaho
Post Falls : Kootenai Cancer Center
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Illinois
Chicago : Northwestern University, Robert H. Lurie Comprehensive Cancer Center
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Chicago : University Of Chicago Medical Center
Phase I Biomarker Study (BMS-936558)
Maywood : Loyola University of Chicago, Cardinal Bernardin Cancer Center
NEXT: Subsequent Exposure to Tyrosine Kinase Inhibition at Recurrence After Adjuvant Therapy in Renal Cell Carcinoma
Skokie : Edward H. Kaplan, M.D., & Associates
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Indiana
Evansville : Deaconess Clinic
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Fort Wayne : Fort Wayne Oncology & Hematology, Inc
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Goshen : IU Health Goshen
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Greenwood : Urology of Indiana Updated
Phase 3 Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (RCC)
Indianapolis : Indiana University Melvin and Bren Simon Cancer Center
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
View More »
Indianapolis : IU Health Central Indiana Cancer Centers
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Indianapolis : Community Regional Cancer Center
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Indianapolis : Franciscan St. Francis Health - Franciscan Physician Network Oncology and Hematology Specialists Updated
Phase 3 Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (RCC)
Lafayette : Horizon Oncology Research
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Muncie : IU Health at Ball Memorial Hospital Cancer Center
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Munster : Monroe Medical Associates
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Newburgh : Oncology Hematology Associates of SW Indiana
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
South Bend : Northern Indiana Cancer Research Consortium
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Iowa
Sioux City : Siouxland Hematology Oncology Associates, LLP, Nylen Cancer Center
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Kansas
Kansas City : University of Kansas Medical Center
A Study to Evaluate the Effectiveness of 5-Azacitidine and Bevacizumab in Advanced Renal Cell Carcinoma
Topeka : Stormont-Vail Cotton O'Neil Cancer Center
A Study to Evaluate the Effectiveness of 5-Azacitidine and Bevacizumab in Advanced Renal Cell Carcinoma
Wichita : Cancer Center of Kansas
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Wichita : Cancer Center of Kansas
NEXT: Subsequent Exposure to Tyrosine Kinase Inhibition at Recurrence After Adjuvant Therapy in Renal Cell Carcinoma
Kentucky
Hazard : Kentucky Cancer Clinic
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Paducah : Purchase Cancer Group
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Louisiana
Baton Rouge : Medical Oncology LLC
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Matairie : East Jefferson General Hospital Updated
Phase 3 Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (RCC)
Metairie : Metairie Oncologists
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Maryland
Baltimore : Sidney Kimmel Comprehensive Cancer Center at John Hopkins Hospital
A Safety Study of LBH589 (Panobinostat) and RAD001 (Everolimus) to Stabilize Kidney Cancer
Baltimore : Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins
Nivolumab (BMS-936558; MDX-1106) in Combination With Sunitinib, Pazopanib, or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma (RCC)
Baltimore : The Bunting-Blaustein Cancer Research Building
Phase I Biomarker Study (BMS-936558)
Massachusetts
Boston : Beth Israel Deaconess Medical Center
Arterial Spin Labeling Blood Flow MRI for Evaluation of Response to Antiangiogenic and Targeted Therapies of Renal Cell Carcinoma (RCC)
Boston : Dana-Farber Cancer Institute
Arterial Spin Labeling Blood Flow MRI for Evaluation of Response to Antiangiogenic and Targeted Therapies of Renal Cell Carcinoma (RCC)
Boston : Beth Israel Deaconess Medical Center
Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma
Boston : Dana-Farber Cancer Institute
Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma
Boston : Beth Israel Deaconess Medical Center
Biomarker Trial of Everolimus in Patients With Advanced Renal Cell Carcinoma
View More »
Boston : Tufts Medical Center
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Boston : Beth Israel Deaconess Medical Center`
Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma
Boston : Dana-Farber Cancer Institute
Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma
Boston : Massachusetts General Hospital
Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma
Boston : Beth Israel Deaconess Medical Center
Nivolumab (BMS-936558; MDX-1106) in Combination With Sunitinib, Pazopanib, or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma (RCC)
Boston : Dana Farber Cancer Inst
Phase I Biomarker Study (BMS-936558)
Boston : Massachusetts General Hospital Cancer Center
Safety Study of MGA271 in Refractory Cancer
Michigan
Ann Arbor : St. Joseph Mercy Hospital
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Detroit : Karmanos Cancer Institute / Wayne State University
A Phase 1b Study of SGN-75 in Combination With Everolimus in Patients With Renal Cell Carcinoma
Detroit : Henry Ford Hospital
Association Between Hepatitis C Infection and Renal Cell Carcinoma
Grand Rapids : Cancer and Hematology Centers of Western Michigan
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Grand Rapids : Cancer and Hematology Clinics of Western Michigan - Spectrum Health Updated
Phase 3 Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (RCC)
View More »
Wyoming : Metro Health Cancer Care
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Minnesota
Rochester : Mayo Clinic
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Missouri
St Louis : Research Site
AMG 172 First in Human Study in Patients With Kidney Cancer
Montana
Great Falls : Sletten Cancer Specialists
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Nebraska
Omaha : Methodist Cancer Center
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Omaha : Missouri Valley Cancer Consortium
NEXT: Subsequent Exposure to Tyrosine Kinase Inhibition at Recurrence After Adjuvant Therapy in Renal Cell Carcinoma
Nevada
Las Vegas :
Study of GDC-0980 Versus Everolimus in Patients With Metastatic Renal Cell Carcinoma Who Have Progressed on or Following Vascular Endothelial Growth Factor- (VEGF) Targeted Therapy
New Hampshire
Lebanon : Dartmouth-Hitchcock Medical Center
Nivolumab (BMS-936558; MDX-1106) in Combination With Sunitinib, Pazopanib, or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma (RCC)
Manchester : Dartmouth-Hitchcock Medical Center
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
New Jersey
Elizabeth : Trinitas Regional Medical Center
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Somerville : Somerset Hematology Oncology Associates
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
New Mexico
Albuquerque : Presbyterian Medical Group
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Albuquerque : University of New Mexico Cancer Care Alliance
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
New York
Manhasset : Biomedical Research Alliance of New York, LLC
Study for high risk recurrence of renal cell carcinoma after surgical treatment
View More »
Albany : New York Oncology Hematology, PC
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Albany : Albany Medical Center Updated
Phase 3 Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (RCC)
Buffalo : Roswell Park Cancer Institute
A Safety Study of LBH589 (Panobinostat) and RAD001 (Everolimus) to Stabilize Kidney Cancer
Buffalo : Roswell Park Cancer Institute
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Lake Success : NYU Langone Arena Oncology
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
New York : Research Site
A Phase 1 Study to Evaluate MEDI4736
New York : Memorial Sloan Kettering Cancer Center
A Phase 1b Study of SGN-75 in Combination With Everolimus in Patients With Renal Cell Carcinoma
New York : Tisch Cancer Institute at Mount Sinai Medical Center
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
New York : Memorial Sloan Kettering Cancer Center
Everolimus and Bevacizumab in Advanced Non-Clear Cell Renal Cell Carcinoma (RCC)
New York : Weill Cornell Medical College
Neoadjuvant Pazopanib in Renal Cell Carcinoma
Nyack : Hematology Oncology Associates of Rockland
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
North Carolina
Chapel Hill : North Carolina Cancer Hospital (UNC)
Neoadjuvant Pazopanib in Renal Cell Carcinoma
Charlotte : Carolinas HealthCare System
Neoadjuvant Pazopanib in Renal Cell Carcinoma
Charlotte : Blumenthal Cancer Center
Nivolumab (BMS-936558; MDX-1106) in Combination With Sunitinib, Pazopanib, or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma (RCC)
Durham : Duke University Medical Center
Biomarker Trial of Everolimus in Patients With Advanced Renal Cell Carcinoma
Durham : Duke University Medical Center
Phase I Biomarker Study (BMS-936558)
View More »
Pinehurst : First Health of the Carolinas
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Ohio
Cleveland : Cleveland Clinic, Taussig Cancer Institute
NEXT: Subsequent Exposure to Tyrosine Kinase Inhibition at Recurrence After Adjuvant Therapy in Renal Cell Carcinoma
Cleveland : Cleveland Clinic
Nivolumab (BMS-936558; MDX-1106) in Combination With Sunitinib, Pazopanib, or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma (RCC)
Middletown : Signal Point Clinical Research Center
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Wooster : Lawrence M. Stallings, M.D.
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Oklahoma
Oklahoma City : Mercy Physicians Of Oklahoma
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Oregon
Portland : Providence Portland Med Ctr
Phase I Biomarker Study (BMS-936558)
Springfield : Willamette Valley Cancer Institute
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Pennsylvania
Bethlehem : St. Luke's Hospital - Bethlehem Campus Updated
Phase 3 Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (RCC)
Danville : Geisinger Medical Center
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Gettysburg : Gettysburg Cancer Center
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Philadelphia : Fox Chase Cancer Center
NEXT: Subsequent Exposure to Tyrosine Kinase Inhibition at Recurrence After Adjuvant Therapy in Renal Cell Carcinoma
Philadelphia : Fox Chase Cancer Center
Nivolumab (BMS-936558; MDX-1106) in Combination With Sunitinib, Pazopanib, or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma (RCC)
View More »
Philadelphia : Fox Chase Cancer Center
Phase I Biomarker Study (BMS-936558)
Philadelphia : Hospital of the University of Pennsylvania/Abramson Cancer Center
Safety Study of MGA271 in Refractory Cancer
Pittsburgh : Allegheny Cancer Center
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Pittsburgh : University of Pittsburgh Medical Center
NEXT: Subsequent Exposure to Tyrosine Kinase Inhibition at Recurrence After Adjuvant Therapy in Renal Cell Carcinoma
Pittsburgh : Upmc Cancer Pavilion
Phase I Biomarker Study (BMS-936558)
State College : Mount Nittany Medical Center
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
West Reading : Berks Hematology Oncology Associates
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Rhode Island
Cranston : Hematology and Oncology Associates of Rhode Island
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Providence : Miriam Hospital, The
A Phase 1b Study of SGN-75 in Combination With Everolimus in Patients With Renal Cell Carcinoma
South Carolina
Charleston : Medical University of South Carolina
A Phase 2 Study of ASONEP™ to Treat Unresectable and Refractory Renal Cell Carcinoma
Charleston : MUSC Hollings Cancer Center
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Charleston : Medical University of South Carolina (MUSC)
Neoadjuvant Pazopanib in Renal Cell Carcinoma
Hilton Head : South Carolina Cancer Specialists
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Myrtle Beach : Carolina Urologic Research Center Updated
Phase 3 Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (RCC)
Tennessee
Germantown : The Jones Clinic, PC
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Nashville : Vanderbilt Univeristy Medical Center
Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma
Nashville : Tennessee Oncology, Pllc
Nivolumab (BMS-936558; MDX-1106) in Combination With Sunitinib, Pazopanib, or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma (RCC)
Nashville : Sarah Cannon Research Institute
Safety Study of MGA271 in Refractory Cancer
Texas
Austin : Texas Oncology: Austin North
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Bedford : Texas Oncology: Bedford
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Dallas : Texas Oncology, PA
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Fort Worth : Texas Oncology: Fort Worth
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Houston : Houston Cancer Center
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
View More »
Houston : Texas Oncology: Houston Memorial City
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Lubbock : Joe Arrington Cancer Research and Treatment Center
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
San Antonio : CTRC at The UT Health Science Center at San Antonio
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Virginia
Lynchburg : Lynchburg Hematology Oncology Clinic, Inc.
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Norfolk : Urology of Virginia Updated
Phase 3 Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (RCC)
Washington
Bremerton : Harrison HealthPartners Bremerton Hematology & Oncology
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Kirkland : Cascade Cancer Center
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Seattle : Seattle Cancer Care Alliance / University of Washington
A Phase 1b Study of SGN-75 in Combination With Everolimus in Patients With Renal Cell Carcinoma
Seattle : Group Health Medical Centers
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Seattle : University of Washington, Seattle Cancer Care Alliance
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
View More »
Spokane : Rockwood Clinic
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Wisconsin
Madison : University Of Wisconsin Carbone Cancer Center
Phase I Biomarker Study (BMS-936558)
Milwaukee : University of Wisconsin, Clinical Cancer Center
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Algeria
Alger : Novartis Investigative Site
A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma
Oran : Novartis Investigative Site
A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma
Australia
Adelaide : Royal Adelaide Hospital
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Greenslopes : Gallipoli Medical Research Foundation: Greenslopes Private Hospital
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Heidelberg : Austin Hospital
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Herston : Royal Brisbane & Women's Hospital
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Kurralta Park : Ashford Cancer Centre
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
View More »
Launceston : Gallipoli Medical Research Foundation: Launceston General Hospital
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Melbourne : Alfred Hospital
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Perth : Royal Perth Hospital
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Randwick : Prince of Wales Hospital
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Wahroonga : Sydney Adventist Hospital Ltd.
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Wolloongabba : Princess Alexandra Hospital
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Canada
Calgary : Local Institution
Nivolumab (BMS-936558; MDX-1106) in Combination With Sunitinib, Pazopanib, or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma (RCC)
Edmonton : Local Institution
Nivolumab (BMS-936558; MDX-1106) in Combination With Sunitinib, Pazopanib, or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma (RCC)
Toronto : University Health Network, Princess Margaret Hospital
A Study of Neoadjuvant Sutent for Patients With Renal Cell Carcinoma
Toronto : Toronto General Hospital
Efficacy of Ultrasound Contrast Agent to Assess Renal Masses
Vancouver : Local Institution
Nivolumab (BMS-936558; MDX-1106) in Combination With Sunitinib, Pazopanib, or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma (RCC)
China
Beijing : Beijing Cancer Hospital
Sorafenib Combined With Chemotherapy for Renal Collecting Duct Carcinoma
Chengdu : West China Hospital
Sorafenib Combined With Chemotherapy for Renal Collecting Duct Carcinoma
Guangzhou : Sun Yat-sen university cancer center
Sorafenib Combined With Chemotherapy for Renal Collecting Duct Carcinoma
Shenyang : Shenyang general hospital of Shenyang military command
Sorafenib Combined With Chemotherapy for Renal Collecting Duct Carcinoma
Xi'an : Xijing Hospital
Sorafenib Combined With Chemotherapy for Renal Collecting Duct Carcinoma
France
Villejuif : Research Site
AMG 172 First in Human Study in Patients With Kidney Cancer
Germany
Berlin : Section Sports Medicine, Charité Universitätsmedizin Berlin, Hindenburgdamm 30
Exercise for Patients With Renal Cell Cancer Receiving Sunitinib
Freiburg : iOMEDICO
Tumor Registry of Advanced Renal Cell Carcinoma
Heidelberg : Research Site
AMG 172 First in Human Study in Patients With Kidney Cancer
India
Indore : Novartis Investigative Site
A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma
Pune : Novartis Investigative Site
A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma
Ireland
Cork : Cork University Hospital
Second-line Pazopanib Renal Cell Carcinoma (RCC) Study
Dublin : Mater Misericordiae University Hospital
Second-line Pazopanib Renal Cell Carcinoma (RCC) Study
Dublin : Mater Private Hospital
Second-line Pazopanib Renal Cell Carcinoma (RCC) Study
Dublin : The Adelaide & Meath Hospital Dublin incorporating the National Children's Hospital
Second-line Pazopanib Renal Cell Carcinoma (RCC) Study
Dublin : Beaumont Hospital
Second-line Pazopanib Renal Cell Carcinoma (RCC) Study
View More »
Galway : Galway University Hospital
Second-line Pazopanib Renal Cell Carcinoma (RCC) Study
Limerick : Mid-Western Regional Hospital
Second-line Pazopanib Renal Cell Carcinoma (RCC) Study
Waterford : Waterford Regional Hospital
Second-line Pazopanib Renal Cell Carcinoma (RCC) Study
Japan
Fukuoka-shi : Kyusyu University Hospital
Temsirolimus (Torisel) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)
Osakasayama : Kinki University Hospital
Temsirolimus (Torisel) Special Investigation (Regulatory Post Marketing Commitment Plan)
Jordan
Amman : Novartis Investigative Site
A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma
Korea, Republic of
Seoul : Seou National University Hospital
A Phase II Study of Axitinib in Metastatic Non-clear Cell Renal Cell Carcinoma Patients Previously Treated With Temsirolimus
Lebanon
Beirut : Novartis Investigative Site
A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma
Russian Federation
Kazan : Novartis Investigative Site
A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma
Moscow : Novartis Investigative Site
A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma
Samara : Novartis Investigative Site
A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma
Ulyanovsk : Novartis Investigative Site
A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma
Saudi Arabia
Riyadh : Novartis Investigative Site
A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma
Singapore
Singapore : National Cancer Centre Singapore
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
South Africa
Cape Town : Novartis Investigative Site
A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma
Durban : Novartis Investigative Site
A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma
Parktown : Novartis Investigative Site
A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma
Sweden
Stockholm : Karolinska University Hospital
Second-line Pazopanib Renal Cell Carcinoma (RCC) Study
Turkey
Many Locations :
Duration of Treatment With Tyrosine Kinase Inhibitors in the Treatment of Metastatic Renal Cell Carcinoma
United Kingdom
Cambridge : Cambridge University Hospitals NHS Foundation Trust
HYPAZ: Hypertension Induced by Pazopanib
London :
Study of GDC-0980 Versus Everolimus in Patients With Metastatic Renal Cell Carcinoma Who Have Progressed on or Following Vascular Endothelial Growth Factor- (VEGF) Targeted Therapy